Oncology Central
@OncologyCentral
Followers
5,263
Following
3,855
Media
1,332
Statuses
8,120
Oncology Central, part of Taylor and Francis, is the online resource for #oncology professionals.
Joined January 2013
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Errejón
• 224716 Tweets
Mario
• 112068 Tweets
الزمالك
• 58645 Tweets
Sumar
• 56097 Tweets
Mourinho
• 42592 Tweets
Mudryk
• 37902 Tweets
Lyon
• 37094 Tweets
Onana
• 32143 Tweets
#الاتحاد_الرياض
• 30925 Tweets
McConnell
• 25869 Tweets
Guanajuato
• 24665 Tweets
Mitch
• 23575 Tweets
Ten Hag
• 22937 Tweets
السوبر المصري
• 16063 Tweets
Mazraoui
• 14320 Tweets
Abdelaziz Barrada
• 14292 Tweets
Eriksen
• 13695 Tweets
#FBvMUN
• 12901 Tweets
Ugarte
• 12660 Tweets
Amad
• 12173 Tweets
Zirkzee
• 12084 Tweets
#18YearsOfTaylorSwift
• 11947 Tweets
The COVID-19 pandemic has resulted in many patients avoiding visiting hospitals. Could a cancer diagnosis crisis be on the horizon due to the numerous missed diagnoses? Find out in our exclusive interview with
@ProfKarolSikora
.
3
49
134
The COVID-19 pandemic has resulted in many conditions being neglected as patients avoid visiting hospitals. Could a cancer diagnosis crisis be on the horizon due to the numerous missed diagnoses? Find out in our exclusive interview with
@ProfKarolSikora
.
0
21
91
“I wish I could hug you.” Read the powerful Editorial by
@NarjustDumaMD
from an oncologist’s perspective on patient interactions during the
#COVID19
pandemic on
@OncologyCentral
now.
2
14
21
Researchers at the
@sangerinstitute
and
@broadinstitute
have validated the two largest
#CRISPR
-Cas9 genetic screens across 25 different cancer types. Once integrated, the datasets will bring us a step closer to the Cancer Dependency Map.
0
12
22
Leading patient advocate, Ginny Mason (
@IBCResearch
), recently spoke to
@LouisJGautier
(
@FutureOncol_FSG
) about her journey from diagnosis with inflammatory
#BreastCancer
, her 20+ years of experience in advocacy and how to effect change in cancer research
0
7
22
Did you know that 1 in 4 women do not attend their cervical screening test? We are supporting
#SmearforSmear
to spread the word that testing saves lives
Check out our 🆓cervical content:
0
20
17
Less than 2 weeks until
@OncologyCentral
@futuresciencegp
attend
@ASCO
!
Watch the video to find out who is attending and what we are looking forward to.
#ASCO18
1
14
17
Emerging
#immunotherapy
and strategies for diffuse large B-cell
#lymphoma
- TOP
#Oncology
Central article of the week
http://t.co/VqZ3z1ZLk8
0
19
7
The CEO of
@SU2C
, Sung Poblete, speaks to
@OncologyCentral
about SU2C’s involvement in the
#COVID19
Symptom Tracker app and why it is so important to collect data on at-risk populations including
#cancer
patients and survivors.
0
13
16
Very excited to announce that our latest video is now live! 🎉🎊 Find out about the signs, symptoms & the latest advancements in
#ColorectalCancer
in this video with our editor
@JadeBethParker
Click here >>>
0
9
14
We're delighted to announce the winners of
@OncologyCentral
's 2020
#CapturingCancer
Photography Competition.
0
10
15
Researchers have discovered a previously unknown mechanism of PARP inhibitors, which can initiate a powerful
#immuneresponse
in cancer cells, potentially increasing the number of individuals who can benefit from
#immunotherapy
. Click the image for the full news story:
0
8
15
Entries are now open for the Capturing Cancer: Oncology Central Photography Competition! 📸 Enter your images to be in with a chance of winning a US $100 Amazon voucher plus many more prizes 🎉
0
11
14
Can we win the evolutionary arms race with hyper-mutant cancers? Find out about a study from
@ICR_London
investigating the genetic makeup of highly evolving stomach and gullet cancers in the battle to optimize
#immunotherapy
.
0
9
15
A must watch video - If you want to find out more about immunotherapy - Register for our FREE CME online symposium -
What is
#immunotherapy
? Learn how Dr. Jim Allison's work has changed the way we treat cancer.
#TIME100
#endcancer
2
87
98
0
23
16
A recent clinical study from The Institute of Cancer Research has shown that the immunotherapy drug pembrolizumab can be used in head and neck cancers to prolong survival more than the standard extreme chemotherapy treatment.
@ICR_London
0
1
15
NEWS: ‘Breakthrough’ prostate cancer test could cut diagnosis time from weeks to days
0
8
15
A study into 12,000 tumors has confirmed thousands of mutational signatures for cancer and revealed 58 new patterns, suggesting that there are causes of cancer that are not fully understood yet. Find out more here on
@OncologyCentral
>>>
1
8
14
BREAKING NEWS: Revolutionary new blood test could detect eight types of cancer
0
12
14
How is artificial intelligence changing
#clinicaltrial
feasibility and recruitment? Listen to our latest podcast with
@woutbrusselaers
to find out:
@deep6ai
0
11
11
What are some of the emerging targets in
#precisionmedicine
? Find out the answer in our panel discussion! Register here >>>
In association with:
@Agendia
@sengenics
@labcorp
@KRASKickers
0
10
14
BREAKING NEWS: NHS patients to benefit from Europe’s first full access deal on the breakthrough CAR-T therapy
#Kymriah
.
Patients with certain forms of leukemia are expected to receive the therapy within weeks, after NICE also green-lighted the treatment.
0
7
12
BREAKING NEWS: a drug that targets mutated versions of the ACVR1 gene, which is found in diffuse intrinsic pontine
#glioma
, could become the world's first treatment for this deadly pediatric brain cancer.
@ICR_London
0
6
13
What is a sentinel lymph node
#biopsy
and how can it help us accurately diagnose and stage head and neck tumours? Watch our latest video with
@MakeSenseCmpn
to find out
#MakeSensecampaign
#headandneckcancer
#EHNS
0
9
10
Missed our immuno-onc symposium? You can still watch the
#OCImmuno17
talks online - register here
0
14
14
Don't forget you can still watch our recent RTK signaling webinar on demand! Click below to gain access
1
21
13
Free
#CME
accredited online symposium: 'Practical clinical aspects of immuno-oncology' Register now!
#immunotherapy
0
16
13
'Astounding' second-chance cancer drug heading for FDA approval
0
17
13
Why is a multidisciplinary team crucial for the treatment of
#headandneckcancer
? Watch our latest video with
@MakeSenseCmpn
to find out
#MakeSenseCampaign
#EHNS
0
6
11
To mark
#TNBCDay
why not check out our infographic exploring the key facts of triple-negative
#breastcancer
?
#tnbc
0
16
11
We are delighted to announce the finalists for our
#CapturingCancer
photography competition! Take a look and vote for your favorite:
0
15
10
Registration and abstract submission for the 2018
@NCRI_partners
Cancer Conference is now live! Sign up today to discover the latest advances in
#cancerresearch
and benefit from earlybird rates -
#NCRI2018
0
12
12
Which cancer indications are best suited to organoid-based research? Register for our expert panel discussion to find out Experts include Robert Vries
@_Hubrecht
, David Tuveson
@CSHL
& Sara Boers
0
6
10
Mirvetuximab soravtansine has demonstrated great potential as a novel therapeutic strategy for
#ovariancancer
- discover details of the Phase III Forward I trial first here:
0
13
13
We are supporting
#SmearForSmear
to spread the word that cervical screening saves lives
@JoTrust
@eveappeal
Free to access case report on
#immunotherapy
for cervical cancer:
0
5
13
Just how far has cancer research progressed in the last 50 years? What have been the key discoveries?
Check out our interactive timeline and editorial to find out.
0
11
13
BREAKING NEWS: A new 'barcoding' test could diagnose an individual’s specific type of colorectal cancer in a matter of hours, rather than the months it can take using existing tools.
1
9
12
Research from
@ICR_London
has revealed that a specific micro RNA could be involved in resistance to chemotherapy in
#bileductcancer
, making it a new potential drug target.
0
7
13
We are delighted to announce that
@gulleyj1
will be presenting at our online symposium
#immunotherapy
#oncology
1
7
13
Recent updates for optimizing outcomes and treatment sequences in EGFR mutation-positive
#NSCLC
published in
@fsgfon
. Read the
#openaccess
review here:
0
6
10
Find out key highlights from
#ASCO19
in this video roundup from our Editor
@JadeBethParker
Visit our news section to find out more!
0
2
11
BREAKING NEWS: A novel urine test could diagnose aggressive
#prostatecancer
and predict whether patients will require treatment up to 5 years earlier than standard clinical methods.
0
5
11
If you are at ESMO GI this week make sure to visit Booth 34 to find out more about Oncology Central and to receive a free gift! #
#WorldGI
0
21
12
NICE has released final draft guidance recommending pemigatinib (Pemazyre) for FGFR2
#cholangiocarcinoma
. Read up on this positive news from
@Incyte
and all the trial data on
@OncologyCentral
, as well as the recent drug evaluation on
@FutureOncol_FSG
0
5
12
We very are excited to announce that Subbaya Subramanian will be presenting at our online symposium!
#immunotherapy
1
15
12
We are excited to announce that
@HosseinBorghaei
will be presenting at our online symposium
#immunotherapy
#oncology
1
16
12
BREAKING NEWS: A major trial has demonstrated that fulvestrant–palbociclib combination therapy may prolong survival and delay the need for chemotherapy in women with advanced breast cancer
#ESMO18
1
8
12
Uncovering the genetics of
#cancer
... Watch the latest video in our series here!
@sangerinstitute
@Video_FSG
1
17
12
0
24
12
NEWS: Novel tumor-targeted MRI contrast designed, based on human proteins
1
20
10
The latest
#openaccess
article in
@fsgfon
evaluates the
#safety
of HTX-019 in
#cancer
patients. Read the full article here:
0
7
6
Could targeting Nrp1 help improve immunotherapy? Read the news story here:
0
16
11
@CICS_DR_MARQUEZ
@SN_CICS
@HosseinBorghaei
@erinforever14
@arturosuplee27
@CICS_KPFI
@Immuneadvisors
@RAMOSERIK
@MarkVerburg6
@gilbertoungson
@DurazoAlberto
Thank you all, I hope you enjoy the immuno-oncology symposium. If you have any questions please feel free to inbox me !
3
10
10
Miss out on key presentations from
#AACR19
? In our video round up below our Editor
@JadeBethParker
highlights the key news headlines from today plus what to look out for tomorrow!
0
3
10
We are delighted to let you know that
@cancereu
&
@OncologyCentral
have partnered! The ECPC is a voice to over 400 cancer patients organisations – we are extremely proud to collaborate with them and to welcome
@lydiamakaroff
to our Ambassador Panel
0
5
10
LOXO-195, which targets TRKs, showed signs of clinical activity in patients who had
#solidtumors
that harbored NTRK gene fusions. Click the image below for the full news story:
1
8
11
Researchers from
@ICR_London
,
@MayoClinic
and
@UniversityLeeds
have developed
#cancervaccines
using highly mutated cancer cells, which can increase the effectiveness of immunotherapy in mice:
0
2
11
NEWS: How do some tumors avoid immune destruction? Novel mechanism uncovered
1
19
11
Find out more about the potential of
#organoids
in
#cancerresearch
, including how to generate organoids to study cholangiocarcinoma in this exclusive interview. Click the image below for the full news story:
0
2
11
Find out about immunotherapeutic strategies for penile cancer in this commentary article.
1
18
11
Another potential drug target has been found in MIR1249, a micro RNA involved in the genetic rewiring of cancer cells so that they can resist
#chemotherapy
, according to a study from
@ICR_London
.
0
7
11
At Oncology Central HQ we are supporting
#wearitpink
day! Find all our 🆓 breast cancer content:
@breastcancernow
0
7
9
Researchers have discovered a previously unknown mechanism of PARP inhibitors, which can initiate a powerful
#immuneresponse
in cancer cells, potentially increasing the number of individuals who can benefit from
#immunotherapy
. Click the image for the full news story:
0
3
10
Less than 1 week left to register for our free panel discussion! Find out about how we can make trials more patient centric and break down barriers for clinical trials as well as the role of genomics in advancing cancer:
0
6
8
Great to see you are enjoying the symposium! Make sure to visit the virtual booths to find more resources and to submit your questions :)
Online symposium
@OncologyCentral
#CICSON
from Ciudad Obregón Sonora MX and our team from Seattle online also
2
36
26
1
20
11
We're hosting a free online symposium on
#cancer
#immunotherapy
- discover more & register your interest
#oncology
0
18
11
Smear tests prevent 75% of cervical cancers from developing yet 1 in 4 women don't attend when invited. We are supporting
#SmearForSmear
to spread the word that testing saves lives.
Find free cervical cancer content here:
1
14
9
Very excited - our video with
@VictoriaHarmer2
is live! 😊Watch it now to celebrate
#BreastCancerAwarenessMonth
0
8
10
ESMO WCGI: Promising initial results reported for immunotherapy for HCC
#WorldGI
- find out more here:
0
24
11
Researchers from University of California have shown for the first time that
#pembrolizumab
can be effective in treating people with recurrent
#glioblastoma
. Click the image below for the full news story.
0
7
9
Sneak preview of whats coming up in our webinar on disease-stage RTK signaling in lung adenocarcinoma
@Merck_lifesci
0
12
10
Hot off the press 📰: FDA approves first the immuno-oncology combination therapy for advanced renal cell carcinoma
0
11
9
Hi
@pfizer
we are hosting a free CME symposium on the practical clinical aspects of immuno-oncology Please RT
0
13
10
Thanks Chris, it was great to meet you and thank you for your time this morning!
@OncologyCentral
Lovely to meet you guys this morning! Look forward to seeing the completed film 🎬📽
0
16
9
1
16
10
How could
#chemotherapy
targeting be improved? Read about the world’s first clinical study trialing acoustic cluster therapy at
@royalmarsdenNHS
and
@ICR_London
:
0
6
9
BREAKING NEWS: Nivolumab given the green light by NICE for non-small cell lung cancers
0
16
9
An update on genomic-guided therapies for pediatric solid tumors
0
14
10
Engineers have developed a 'magnetic tentacle robot' that can access even the most minuscule bronchial tubes in the lung. Find out more >>>
@STORM_Lab_
1
5
10
Great explanation from Marc Ernstoff of T-cell memory, exhaustion & reinvigoration - Login to hear more
#OCImmuno17
0
20
10
To mark
#SarcomaAwarenessWeek
we spoke with Robin Jones, a specialist in the treatment sarcomas. Extended interview:
0
20
10
@CICS_DR_MARQUEZ
@SN_CICS
@HosseinBorghaei
@erinforever14
@arturosuplee27
@CICS_KPFI
@Immuneadvisors
@RAMOSERIK
@MarkVerburg6
@gilbertoungson
@DurazoAlberto
Just to let you know other speakers include James Gulley, Roy Herbst & Susan Slovins You can register for free here:
1
14
10
Further insight into AE37 peptide vaccination in prostate cancer. Read the article here:
1
16
10
FDA Approves First Cancer Treatment for Any Solid Tumor With a Specific Genetic Feature via
@practiceupdate
0
17
10
A novel artificial intelligence and biosensor device has been developed to monitor if live
#cancercells
remain after
#chemotherapy
treatment. Click the image below for the full news story:
1
6
10
Results from the DART clinical trial indicate that ipilimumab plus nivolumab may be beneficial to patients with high-grade neuroendocrine carcinoma
@PatelOncology
#AACR19
0
4
10
A report released today suggests that a
#GeneticTest
, which can predict how well drugs will work in the body, may be available on the NHS next year. Could a
#PersonalizedHealthcare
system be on the horizon for
#Cancer
treatment? Read the news here >>>
0
6
8
With over 5000 abstracts accepted, it can be a tricky to know which talks to listen out for at
#ASCO19
! To help you make the most of the biggest cancer conference, we have selected key talks for you to attend.
0
3
9
Our free panel discussion is starting in just 1 hour!
Register to find out what the future holds for tumor mutational burden
0
6
10
Immunotherapy, the next generation of cancer treatment. Gain access to the PDF here
1
4
10
Great day of talks at the
#OCImmuno17
symposium today. Excited for tomorrow's fantastic speakers including Roy Herbst from Yale!
0
21
10
Our Editor
@JadeBethParker
today provided us with her highlights from
#ESMO18
- catch up on all the news by clicking here:
0
6
9
All eyes are on Atlanta with
#AACR19
just around the corner! To help you navigate this huge conference, our Editor
@JadeBethParker
has selected key talks for you to attend
1
1
8
Interested in FREE access to peer-reviewed
#oncology
content? Sign up today for FREE to gain access
1
15
10